Share

IONQ’s Revenue Growth Is Impressive

IONQ Analysis

IonQ Q3 2024 Financial Results

Quarter Ended September 30, 2024

Revenue
$12.4M
+102% Year-over-Year Growth
New Bookings
$63.5M
Q3 2024
Cash & Investments
$382.8M
As of September 30, 2024

Key Financial Metrics

Net Loss $52.5M
Adjusted EBITDA Loss $23.7M
2024 Revenue Guidance $38.5M – $42.5M

Major Q3 Achievements

AFRL Contract

Secured $54.5M contract with US Air Force Research Lab

Strategic Acquisition

Signed agreement to acquire Qubitekk for quantum networking expansion

Key Partnerships

New collaborations with AstraZeneca, Ansys, and University of Maryland

Looking at IonQ’s Q3 2024 financial results, the 102% year-over-year revenue growth (from $6.1M to $12.4M) stands out as particularly attractive to investors for several key reasons:

First, the growth is backed by substantial new bookings of $63.5M in Q3, including a major $54.5M contract with the U.S. Air Force Research Lab. This suggests the revenue growth isn’t just a one-off spike but has potential to continue, as these bookings should convert to revenue over time.

Second, IonQ is demonstrating commercial traction in multiple sectors through new partnerships with industry leaders like AstraZeneca (pharmaceuticals) and Ansys (engineering software). This diversification across industries suggests broader market validation of their quantum computing technology.

The company also shows strong financial stability with $382.8M in cash and investments, giving them runway to continue investing in growth while navigating the path to profitability. Additionally, management’s confidence is reflected in their raised 2024 revenue guidance to $38.5M-$42.5M.

For investors looking to get exposure to the quantum computing sector, this combination of triple-digit revenue growth, major government contracts, commercial partnerships, and solid cash position could make IonQ an attractive option, despite current operating losses which are common for companies at this stage in emerging technology sectors.

Editor’s Note: This analysis the first in a series of company studies that will be rolled out in this publication in going forward. Please review the Disclosure and Risk Disclaimer and bear in mind that the analysis you see here is for informational purposes and should not be taken as investment advice.

If you liked this feature you can get nore useful trading info and strategies from you can also get more useful trading info like How To Trade Single PrintsStockbee’s Trading Method Blackrock’s Aladdin, A Tutorial On Market StructureHow To Trade With the BPSPX, The ICT Candle Counting MethodHow To Pass A Trader Evaluation & Get FundedFive Trading Lessons I Learned From CitadelThe Top Step Trader ReviewICT Liquidity RunsHow To Trade The Options Chart & The Falang Futures Algo  and How To Use Volume To Trade Like Banks & Institutions

You may also like